ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1179

Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study

Roxana Gonzalez Mazario1, Jorge Juan Fragio Gil1, Marta De la Rubia Navarro1, Cristobal Pavez Perales1, Samuel Leal Rodriguez2, Jose Ivorra Cortes1, Luis Gonzalez Puig3, Elena Grau Garcia2, Elvira Vicens Bernabeu1, F Ortiz-Sanjuan1, Rosa Negueroles Albuixech1, Cristina Alcañiz Escandell2, Jose Eloy Oller Rodriguez1, Inmaculada Chalmeta Verdejo1, Isabel Martinez Cordellat1, Carmen Najera Herranz1, Ines Canovas Olmos1, Antonio Cañada Martínez4 and Jose Andres Roman Ivorra1, 1Rheumatology Department. HUP La Fe, Valencia, Spain, 2Rheumatology Department. HUP La Fe, Valencia, Comunidad Valenciana, Spain, 3Rheumatology Department. HUP La Fe, Torrente ( Valencia), Spain, 4HUP La Fe, Valencia, Spain

Meeting: ACR Convergence 2020

Keywords: Cardiovascular, rheumatoid arthritis, Ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Cardiopulmonary Aspects

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To assess the Cardiovascular Risk (CV) in Rheumatoid Arthritis (RA) patients using carotid ultasonography additionally to the traditional CV risk factors.

Methods: A single center cross-sectional case control study was performed. Inclusion criteria were adult patients who fulfilled the ACR/EULAR 2010 RA criteria (cases) and matched healthy adults in terms of age, sex and CV risk factors (controls). Population over 75 years old, patients with established CV disease and/or chronic kidney disease (from III Stage) were excluded. Controls with other inflammatory diseases, pregnant women or any malignancy were also excluded. This study was performed from July-2019 to January-2020.

CV risk assessment included risk factors collection such as serum biomarkers (glucose, total cholesterol, HDL cholesterol, LDL cholesterol, Triglycerides, Creatinine, Glomerular filtrate [CKD-EPI], uric acid, C reactive protein [CRP], Erythrocyte Sedimentation Rate [ESR]), Body Mass Index, life style habits, family history of early CV disease.

The US evaluator was blinded to the case/control condition and evaluated the carotid artery by using B-mode imaging of the arterial wall, color doppler flow analysis, presence of plaques, plaque number and measured the intima-media thickness in both right and left carotid.

Statistical analysis was performed with R software (3.6.1 version) and included a multivariate variance analysis (Manova) and a negative binomial regression adjusted by confounding factors.

Results: Overall, a total of 200 cases and 111 healthy controls were included in the study. Demographical and clinical variables were comparable between cases and controls and are shown in table 1. In both groups a relationship between age, BMI and high blood pressure was detected (p< 0.001). RA disease characteristics are displayed in table 2.

US study revealed a higher IMT in both right and left carotid arteries with greater presence of plaques in patients than in controls (CI 95% [1.542; 3.436], p< 0.001). Plaques were found in both carotid arteries in the 32% of cases and 9.91% of controls. The longer duration of RA was related to a higher presence of carotid plaques (95% [1.015; 1.056], p< 0.001). The age was also related to plaque development (CI 95% [1.051; 1.094], p< 0.001) as seen with high blood pressure (CI 95% [1.124; 2.27], p=0.012). Female sex protected against carotid plaques presence (CI 95% [0.367; 0.856],  p=0-009). US and blood test results are shown in table 3.

Conclusion: RA leads to a higher intima-media thickness and this is related to the disease duration. Traditional risk factor may explain only partially the global CV risk in RA. These findings might support that RA acts as an independent cardiovascular risk factor.

Table 1. Demographic and clinical characteristics of patients and controls.

Table 2. Rheumatoid Arthritis disease characteristics among patients included.

Table 3. Blood test and Ultrasound Results in patients and controls.


Disclosure: R. Gonzalez Mazario, None; J. Fragio Gil, None; M. De la Rubia Navarro, None; C. Pavez Perales, None; S. Leal Rodriguez, None; J. Ivorra Cortes, None; L. Gonzalez Puig, None; E. Grau Garcia, None; E. Vicens Bernabeu, None; F. Ortiz-Sanjuan, None; R. Negueroles Albuixech, None; C. Alcañiz Escandell, None; J. Oller Rodriguez, None; I. Chalmeta Verdejo, None; I. Martinez Cordellat, None; C. Najera Herranz, None; I. Canovas Olmos, None; A. Cañada Martínez, None; J. Roman Ivorra, None.

To cite this abstract in AMA style:

Gonzalez Mazario R, Fragio Gil J, De la Rubia Navarro M, Pavez Perales C, Leal Rodriguez S, Ivorra Cortes J, Gonzalez Puig L, Grau Garcia E, Vicens Bernabeu E, Ortiz-Sanjuan F, Negueroles Albuixech R, Alcañiz Escandell C, Oller Rodriguez J, Chalmeta Verdejo I, Martinez Cordellat I, Najera Herranz C, Canovas Olmos I, Cañada Martínez A, Roman Ivorra J. Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/cardiovascular-risk-assessment-with-carotid-ultrasonography-in-addition-to-the-traditional-cardiovascular-risk-factor-in-rheumatoid-arthritis-a-case-control-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-risk-assessment-with-carotid-ultrasonography-in-addition-to-the-traditional-cardiovascular-risk-factor-in-rheumatoid-arthritis-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology